Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 21.4.2023ratiopharm GmbH (RAT)1585DPazenir 5 mg/ml prášok na infúznu disperziu (plv sif 1x100 mg (liek.inj.skl.))8.5.2023R
 21.4.2023Celltrion Healthcare Hungary Kft. (CLO-2)1914EVEGZELMA 25 mg/ml infúzny koncentrát (con inf 1x4 ml/100 mg (liek.inj.skl.))25.4.2023U
 21.4.2023Celltrion Healthcare Hungary Kft. (CLO-2)1915EVEGZELMA 25 mg/ml infúzny koncentrát (con inf 1x16 ml/400 mg (liek.inj.skl.))25.4.2023U
 21.4.2023CHEPLAPHARM Registration GmbH (CEP-2)64307ZYPADHERA 300 mg prášok a rozpúšťadlo na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x300 mg (liek.inj.skl.) +1x3 ml solv.(liek.inj.skl.))24.4.2023R
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)66464Sodium Iodide (131I) Injection (sol inj 1x74 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75672Sodium Iodide (131I) Injection (sol inj 1x37 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75675Sodium Iodide (131I) Injection (sol inj 1x185 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75680Sodium Iodide (131I) Injection (sol inj 1x370 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75681Sodium Iodide (131I) Injection (sol inj 1x555 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75682Sodium Iodide (131I) Injection (sol inj 1x740 MBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75684Sodium Iodide (131I) Injection (sol inj 1x1,11 GBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75686Sodium Iodide (131I) Injection (sol inj 1x1,48 GBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75688Sodium Iodide (131I) Injection (sol inj 1x1,85 GBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75694Sodium Iodide (131I) Injection (sol inj 1x2,96 GBq (liek.inj.skl.))1.7.2023Z
 21.4.2023GE Healthcare Buchler GmbH & Co. KG (GHB-1)75698Sodium Iodide (131I) Injection (sol inj 1x3,70 GBq (liek.inj.skl.))1.7.2023Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)